packageNatalizumab

natalizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Natalizumab is a monoclonal antibody used to treat multiple sclerosis, including relapsing-remitting forms, and Crohn's disease. It is authorised in the European Union and prescribed under medical supervision, carrying a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q386119 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:natalizumab
ATC codes:L03AD, L04AG03
DrugBank:DB00108
Wikidata:Q386119
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown